학술논문
Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view
Document Type
Article
Author
Source
In Journal of Cystic Fibrosis September 2020 19(5):688-695
Subject
Language
ISSN
1569-1993